In Vivo Selection of anti-glioblastoma DNA aptamer-drug conjugates in an orthotopic patient-derived xenograft model
Caroline D. Doherty, Sonia Jain, Lauren L. Ott, Katie Bakken, Brandon A. Wilbanks, Danielle M. Burgenske, Keenan S. Pearson, Jessica I. G. Griffith, Zichen Tian, Jeffrey A. Meridew, Saigopalakrishna S. Yerneni, William F. Elmquist, Jann Nagina Sarkaria, Louis James Maher III
This study develops and tests DNA aptamer-drug conjugates (ApDCs) for glioblastoma treatment using an in vivo SELEX approach in a patient-derived xenograft model.
NAR Cancer · Jul 27, 2026Peer-reviewedCancer Biology